Pharmaceuticals, Biotechnology and Life Sciences
– Oral KVD900 Primary Endpoint Shows Only 15% Use of Rescue Medication in Patients with Hereditary Angioedema (HAE) – –…
ACIS study meets primary endpoint of improving time to radiographic progression or death in patients with mCRPC BEERSE, Belgium–(BUSINESS WIRE)–FOR…
Grow Pharma will distribute Tilray’s GMP-certified medical cannabis products across the UK New UK agreement gives doctors and patients access…
SHANGHAI & GUILFORD, Conn.–(BUSINESS WIRE)–Drug Farm, a China- and US-based biotechnology company utilizing genetics and AI technologies to discover and…
DUBLIN–(BUSINESS WIRE)–The “Clear Cell Sarcoma – Pipeline Insight, 2021” drug pipelines has been added to ResearchAndMarkets.com’s offering. This report provides…
Expansion of the Board of Directors will support the company’s further growth as an ion channels focused drug discovery CRO…
Final analysis from Phase 3 TITAN study demonstrated apalutamide provided statistically significant overall survival benefit and consistent safety profile in…
Umbralisib (UKONIQ™) granted accelerated approval by US FDA for the treatment of adult patients with relapsed or refractory marginal zone…
MENLO PARK, Calif.–(BUSINESS WIRE)–#PrecisionOncology–Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for population sequencing and cancer, today announced the…
LOS ANGELES–(BUSINESS WIRE)–Turn Therapeutics, a biotechnology company specializing in advanced wound care and infection control, today announced enrollment of the…